Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65 USD | -2.30% | +0.06% | -9.24% |
May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
May. 07 | Transcript : Intra-Cellular Therapies, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 663M | Sales 2025 * | 924M | Capitalization | 6.86B |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | 111M | EV / Sales 2024 * | 9.04 x |
Net cash position 2024 * | 872M | Net cash position 2025 * | 926M | EV / Sales 2025 * | 6.43 x |
P/E ratio 2024 * |
-113
x | P/E ratio 2025 * |
58
x | Employees | 610 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.68% |
Latest transcript on Intra-Cellular Therapies, Inc.
1 day | -2.30% | ||
1 week | +0.06% | ||
Current month | -9.48% | ||
1 month | -9.72% | ||
3 months | -14.08% | ||
6 months | +13.66% | ||
Current year | -9.24% |
Managers | Title | Age | Since |
---|---|---|---|
Sharon Mates
CEO | Chief Executive Officer | 71 | 13-08-28 |
Director of Finance/CFO | 67 | 13-08-28 | |
Michael Halstead
PSD | President | 51 | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
BRD | Director/Board Member | 71 | 14-01-07 |
Joel Marcus
BRD | Director/Board Member | 76 | 13-08-28 |
Director/Board Member | 67 | 14-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.14% | 14 M€ | -3.66% | ||
0.45% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 65 | -2.30% | 783,425 |
24-05-16 | 66.53 | -0.46% | 723,533 |
24-05-15 | 66.84 | +1.72% | 691,551 |
24-05-14 | 65.71 | -0.92% | 696,956 |
24-05-13 | 66.32 | +2.09% | 706,863 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.24% | 6.86B | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ITCI Stock